These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38179769)

  • 1. A Machine Learning Method for Predicting Biomarkers Associated with Prostate Cancer.
    Tong Y; Tan Z; Wang P; Gao X
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):333. PubMed ID: 38179769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis.
    Wang Y; Wang J; Tang Q; Ren G
    PLoS One; 2021; 16(2):e0247827. PubMed ID: 33630978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of metastasis-related genes for predicting prostate cancer diagnosis, metastasis and immunotherapy drug candidates using machine learning approaches.
    Wang Y; Ji B; Zhang L; Wang J; He J; Ding B; Ren M
    Biol Direct; 2024 Jun; 19(1):50. PubMed ID: 38918844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
    Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Network Analysis to Determine CNN1, MYL9, TAGLN, and SORBS1 as Potential Key Genes Associated with Prostate Cancer.
    Li C; Pang L; Jin F; Song Y; Zhou D; Song Y; Li Y; Jin S; Zhang L; Liang W; Shen X; Li J; She B; Wang C; Ma L
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer.
    Li H; Gu J; Tian Y; Li S; Zhang H; Dai Z; Wang Z; Zhang N; Peng R
    Front Immunol; 2022; 13():982628. PubMed ID: 36325340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel biomarkers in prostate cancer diagnosis and prognosis.
    Li W; Xu W; Sun K; Wang F; Wong TW; Kong AN
    J Biochem Mol Toxicol; 2022 Sep; 36(9):e23137. PubMed ID: 35686336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
    Chen X; Wang J; Peng X; Liu K; Zhang C; Zeng X; Lai Y
    Medicine (Baltimore); 2020 Apr; 99(14):e19628. PubMed ID: 32243390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cell division cycle 20 as a candidate biomarker and potential therapeutic target in bladder cancer using bioinformatics analysis.
    Shen P; He X; Lan L; Hong Y; Lin M
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental Phenol and Paraben Exposure Risks and Their Potential Influence on the Gene Expression Involved in the Prognosis of Prostate Cancer.
    Alwadi D; Felty Q; Roy D; Yoo C; Deoraj A
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for Prostate Cancer.
    Hou Q; Bing ZT; Hu C; Li MY; Yang KH; Mo Z; Xie XW; Liao JL; Lu Y; Horie S; Lou MW
    EBioMedicine; 2018 Jun; 32():234-244. PubMed ID: 29861410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
    Lin J; Chen Z; Li Z; Nong D; Li X; Huang G; Hao N; Liang J; Li W
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of prostate cancer bone metastasis related genes and potential therapy targets by bioinformatics and in vitro experiments.
    Jiang H; Liu M; Deng Y; Zhang C; Dai L; Zhu B; Ou Y; Zhu Y; Hu C; Yang L; Li J; Bai Y; Yang D
    J Cell Mol Med; 2024 Aug; 28(15):e18511. PubMed ID: 39098992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and diagnosis of prostate cancer based on hypergraph regularization sparse least partial squares regression algorithm.
    Huang RH; Ge ZL; Xu G; Zeng QM; Jiang B; Xiao GC; Xia W; Wu YT; Liao YF
    Aging (Albany NY); 2024 May; 16(11):9599-9624. PubMed ID: 38829766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer.
    Wang Y; Fan J; Chen T; Xu L; Liu P; Xiao L; Wu T; Zhou Q; Zheng Q; Liu C; Chan FL; Wu D
    Front Endocrinol (Lausanne); 2022; 13():975623. PubMed ID: 36034466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer.
    Alwadi D; Felty Q; Yoo C; Roy D; Deoraj A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
    Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
    Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer.
    Wu X; Long X; Ma C; Cheuk YC; Hu M; Hu J; Jiang H
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome-related prognostic index: Predicting biochemical recurrence and differentiating between cold and hot tumors in prostate cancer.
    Ren C; Wang Q; Wang S; Zhou H; Xu M; Li H; Li Y; Chen X; Liu X
    Front Endocrinol (Lausanne); 2023; 14():1148117. PubMed ID: 37033267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.